Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-04-02 4:32 pm |
N/A 2035-03-31 |
Verrica Pharmaceuticals Inc. | VRCA | Corcoran Gavin Director |
17,502 | $0 | 17,502 (Direct) |
View |
Ownership |
2025-04-02 4:31 pm |
N/A N/A |
Verrica Pharmaceuticals Inc. | VRCA | Corcoran Gavin Director |
0 | $0 | 20 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:52 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Corcoran Gavin Chief R&D Officer |
244,300 | $0 | 244,300 (Direct) |
View |
| 2021-03-17 Option Award |
2021-03-19 4:58 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Corcoran Gavin Chief R&D Officer |
16,001 | $0 | 25,792 (Direct) |
View |
| 2020-06-12 Option Award |
2020-06-15 7:38 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer |
16,002 | $0 | 25,792 (Direct) |
View |
| 2020-06-12 Tax Withholding |
2020-06-15 7:38 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer |
6,211 | $3.46 | 25,792 (Direct) |
View |